EUVIMEDEUVIMED entdecken
Crossref

SPON2 promotes the bone metastasis of lung adenocarcinoma via activation of the NF-κB signaling pathway

Ming Wu, Dewei Kong, Yan Zhang

Bone · 2023-02 · 167 · 116630

DOI: 10.1016/j.bone.2022.116630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2023-02. Verfasst von Ming Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Training Base in Shanghai Gongli Hospital, Ningxia Medical University, Shanghai 200135, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone metastasis severely affects the life span and quality of life of survivors of lung adenocarcinoma (ADC). There is a pressing need to identify viable biomarkers for this incurable, fatal disease. Spondin-2 (SPON2) has been reported to be involved in metastasis and cancer progression, but its role in bone metastasis in patients with lung ADC has rarely been studied. Here, we showed that the upregulation of SPON2 increased the migration, invasion, and epithelial-to-mesenchymal transition of ADC cells in vitro, whereas silencing SPON2 repressed these processes. Consistently, silencing SPON2 significantly reduced the bone metastasis of ADC cells in vivo. Mechanistically, SPON2 activated the nuclear factor-κB (NF-κB) signaling pathway and increased the expression levels of MMP2 and MMP9. Blocking NF-κB using an inhibitor attenuated the SPON2-induced migration and invasion of ADC cells. In addition, we found that SPON2 expression levels were increased in metastatic bone tissues compared to primary ADC tissues. The upregulation of SPON2 was positively correlated with MMP2 and MMP9 expression levels in metastatic bone tissues. In conclusion, these results illustrate that SPON2 plays a key role in ADC by activating the NF-κB pathway to promote bone metastasis, which suggests that it may be a target for future drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsHumansNF-kappa BMatrix Metalloproteinase 2Matrix Metalloproteinase 9Quality of LifeCell MovementSignal TransductionCell Line, TumorNeoplasm MetastasisGene Expression Regulation, NeoplasticCell ProliferationNeoplasm ProteinsExtracellular Matrix Proteins

Stichwörter der Autor:innen

Bone metastasisLung adenocarcinomaNF-κB signalingSPON2

Substanzen

NF-kappa BMatrix Metalloproteinase 2Matrix Metalloproteinase 9SPON2 protein, humanNeoplasm ProteinsExtracellular Matrix Proteins

Autor:innen und Institutionen

  • Postgraduate Training Base in Shanghai Gongli Hospital, Ningxia Medical University, Shanghai 200135, China.
  • Department of Orthopaedics, Gongli Hospital of Pudong New Area, Shanghai 200135, China. Electronic address: rmyyzh@126.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wu, M., Kong, D., & Zhang, Y. (2023). SPON2 promotes the bone metastasis of lung adenocarcinoma via activation of the NF-κB signaling pathway. Bone, 167, 116630. https://doi.org/10.1016/j.bone.2022.116630

Vancouver

Wu M, Kong D, Zhang Y. SPON2 promotes the bone metastasis of lung adenocarcinoma via activation of the NF-κB signaling pathway. Bone. 2023;167:116630. doi:10.1016/j.bone.2022.116630

BibTeX
@article{Wu2023,
  author = {Wu, Ming and Kong, Dewei and Zhang, Yan},
  title = {SPON2 promotes the bone metastasis of lung adenocarcinoma via activation of the NF-κB signaling pathway},
  journal = {Bone},
  year = {2023},
  volume = {167},
  pages = {116630},
  doi = {10.1016/j.bone.2022.116630}
}
Kostenlos starten →